LexisNexis® Legal Newsroom
11th Circuit: MDL Plaintiffs Didn’t Lay Foundation For Admitting Accutane Study

ATLANTA — (Mealey’s) The 11th Circuit U.S. Court of Appeals on May 7 affirmed summary judgment in six federal Accutane cases, finding that the plaintiffs had not shown that their excluded causation expert relied on a new study linking the acne drug to inflammatory bowel disease (IBD) ( In...

$13.6 Million Accutane Judgment Reversed For New Trial To Include 'Numbers' Evidence

TRENTON, N.J. - (Mealey's) A New Jersey appeals court panel on Aug. 5 vacated a $13.6 million Accutane judgment after ruling that the trial judge restricted defendant Hoffman-La Roche Inc.'s use of numbers comparing the total number of Accutane users and the population background rate of inflammatory...

$2M N.J. Accutane Verdict Reversed, 2 Defense Verdicts Affirmed On Appeal

TRENTON, N.J. — (Mealey’s) A New Jersey appeals panel on Aug. 4 vacated a $2,125,617 Accutane bowel injury verdict and affirmed defense verdicts in two other cases tried at the same time ( Gillian Gaghan v. Hoffman-La Roche Inc., et al. , Nos. A-2717-11T2, A-3211-11T2 and A-3217-11T2, N.J...

$25 Million Accutane Verdict Vacated On Appeal In New Jersey On Law Choice, Limitations

TRENTON, N.J. — (Mealey’s) A New Jersey appeals panel on Aug. 11 vacated a $25 million Accutane bowel injury verdict after finding that Alabama’s statute of limitations applied, rather than New Jersey’s, and that the plaintiff’s claim was time-barred ( Andrew McCarrell v...